The rationale for use of benzodiazepine receptor antagonists is based on the so-called benzodiazepine pathogenetic hypothesis of hepatic encephalopathy (HE). To assess the efficacy of flumazenil, a specific benzodiazepine receptor antagonist, in a large and selected population of cirrhotic patients
โฆ LIBER โฆ
Double-blind cross-over study with org OD 14 and placebo in postmenopausal patients
โ Scribed by J. Nevinny-Stickel
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 247 KB
- Volume
- 234
- Category
- Article
- ISSN
- 0003-9128
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Flumazenil for hepatic encephalopathy gr
โ
Dr. Giuseppe Barbaro; Gabriella Di Lorenzo; Maurizio Soldini; Giuseppe Giancaspr
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 90 KB
๐ 1 views
A double-blind cross-over study of nifed
โ
M. B. Finch; S. Copeland; A. P. Passmore; G. D. Johnston
๐
Article
๐
1988
๐
Springer
๐
English
โ 423 KB
A double-blind placebo-controlled study
โ
Simon Carette; Andrei Calin; Jim P. McCafferty; Bruce A. Wallin
๐
Article
๐
1989
๐
John Wiley and Sons
๐
English
โ 759 KB
A double-blind and cross-over comparison
โ
P. J. W. Scott; J. Hosie; M. G. B. Scott
๐
Article
๐
1988
๐
Springer
๐
English
โ 616 KB
Donepezil augmentation of clozapine mono
โ
Rafael Stryjer; Rael Strous; Faina Bar; Ginette Shaked; Roni Shiloh; Silvio Roze
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 57 KB
## Abstract Increasing evidence suggests that the cholinergic system is involved in the pathogenesis of schizophrenia. Donepezil, a central cholinesterase inhibitor, improves psychotic symptomatology in demented patients, however, evidence for its role in the management of active psychosis in schiz
Randomized double-blind placebo-controll
โ
A. H. Momsen; M. B. Jensen; C. B. Norager; M. R. Madsen; T. Vestersgaard-Anderse
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 132 KB
๐ 2 views